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MRI (DCE-MRI)Abstract Purpose: To evaluate the diagnostic accuracy of diffusion-weighted imaging (DWI) in
differentiating benign from malignant breast lesions.
Patients and methods: Forty patients with positive diagnoses at mammography or breast ultra-
sound were included in this study. Patients were imaged with dynamic contrast enhanced MRI
and DWI before biopsy of their breast tumors. Apparent diffusion coefﬁcient (ADC) map was uti-
lized to select the region of interest (ROI) for ADC calculation. DWI was performed using three sets
of b value (0, 400, and 800 s/mm2).
Results: The ﬁnal analysis comprised 40 breast lesions, 18 of which were malignant and 22 were
benign. Signiﬁcant results were obtained between ADC values of benign and malignant lesions
(p< 0.001). The cut-off ADC value for benign and malignant lesions was 1.25 · 10–3 mm2/s.
Conclusion: The present study provides consistent evidence to support DWI as a diagnostic tool
for breast lesion characterization and as a useful adjunct to standard breast MRI protocols in aid-
ing the diagnosis of breast cancer.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Conventional MRI of the breast is mainly based on the com-
bined analysis of the morphological data and enhancement
kinetics of the lesions. This gives information about tumorphysics, vascularity, and vascular permeability. It provides
high sensitivity yet with moderate speciﬁcity for breast cancer
(1), with overlap between benign and malignant lesions (2–6).
Due to the low speciﬁcity of the conventional MRI, an
additional feature is needed to characterize suspicious lesions
in order to decrease the number of invasive breast procedures.
Prior studies with breast MRI and DWI have already
addressed this question and show promising results (7–9).
Diffusion weighted imaging is a novel technique in mag-
netic resonance imaging and has a high sensitivity in the detec-
tion of changes in local biological environment .A signiﬁcant
advantage of diffusion weighted MR imaging is its high
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out the need for intravenous contrast material injection (10).
The diffusion of water in tissue is quantiﬁed by the appar-
ent diffusion coefﬁcient (ADC). Based on the diffusion-
weighted images, an ADC map can be calculated which shows
the ADC value of each voxel in every slice. Restricted water
movement in tumors with high cellularity leads to smaller
ADC values (7).
The objective of this study was to evaluate the role of DWI
with ADC value measurement in differentiating benign from
malignant breast lesions.2. Patients and methods
Forty patients with positive diagnoses at mammography or
breast ultrasound were included in this study which was con-
ducted over a period of 10 months. Patients were imaged with
dynamic contrast enhanced magnetic resonance imaging
(DCE-MRI) and diffusion weighted imaging (DWI) before
biopsy of their breast tumors. Lesions greater than 1 cm in size
were selected for this study because smaller lesions are hardly
identiﬁable on the DWI images. Lesions less than 1 cm in size
or purely cystic lesions were excluded as the latter show no dif-
fusion restriction. Approval for the study was obtained fromFig. 1 A – DCE-MRI shows an inhomogeneously enhancing
retroareolar mass lesion with spiculated margins. B – ADC map
revealed restricted diffusion with a low mean ADC value of
0.7 · 103 mm2/s.the local ethical committee and informed consent was obtained
from all the study subjects. In all patients, MRI was performed
bilaterally, and results were correlated with histopathology.
The age of the patients ranged from 12 to 50 years (mean
age 36.5 ± 9.6).
2.1. MRI protocol
All patients were examined using a 1.5-T MR unit (Achieva,
Philips Medical Systems, Best, The Netherlands) and a dedi-
cated double breast coil. Imaging was performed within days
7–14 of the menstrual cycle for premenopausal women.
Patients were placed in the prone position.
The conventional MRI protocol included the following:
 T2W axial sequence (TR/TE: 4800/120), number of excita-
tion (NEX): 1, slice thickness: 3 mm with no gap, and ﬁeld
of view (FOV): ranged from 280 to 340 mm depending on
the breast size, matrix = 256 · 160 or 256 · 192.Fig. 2 A – DCE-MRI shows an intensely enhancing irregularly
outlined mass lesion in the upper inner quadrant of the left breast
with a curvilinear tail of abnormally enhancing tissue seen directed
anteromedially. B – ADC map revealed restricted diffusion with a
low mean ADC value of 0.81 · 103 mm2/s.
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(NEX): 1, slice thickness: 3 mm, and ﬁeld of view (FOV):
ranged from 280 to 340 mm depending on the breast size,
matrix = 256 · 160 or 256 · 192.
 Axial/sagittal STIR (TR/TE: 2000–7500/55–170), number
of excitation (NEX): 1, slice thickness: 3 mm with no gap,
and ﬁeld of view (FOV): ranged from 280 to 340 mm
depending on the breast size, matrix = 256 · 160 or
256 · 192.
 Five continuous dynamic contrast-enhanced THRIVE 3D
acquisitions were performed (TR/TE: 4.4/1.6, ﬂip angle:
12, and slice thickness: 1 mm). The time taken for each
acquisition was around 1 min.
 Axial DWI with single-shot echo-planar imaging (EPI) was
performed at b values = 0, 400, and 800 s/mm2, TR/TE:
P1036/80, FOV: 350 mm, and slice thickness: 3 mm with
no gaps, NEX= 2, matrix = 256 · 256.
2.2. ADC value measurement
The mean ADC value of the lesion was calculated by position-
ing multiple regions of interest (ROI) over the lesion in consec-
utive image sections. The ROIs may be placed directly onto the
ADC map or copied onto the map from those drawn onFig. 3 A – T2W axial images show multiple bilateral variable sized w
mms to a maximum of 7.5 cm in diameter exhibiting intermediate
enhancement with intrasubstance nonenhancing septations. C – On D
map. The mean ADC value was 1.3 · 103 mm2/s.morphological or b-value DW-MR images. Necrotic areas
were avoided.
2.3. Statistical analysis
Receiver operating characteristic (ROC) curve analyses were
performed to assess the diagnostic performance of the ADC
values in characterization of breast lesions and to determine
suitable ADC cut-off points to separate benign and malignant
lesions. Mann–Whitney U-test was used to compare ADC val-
ues of benign versus malignant lesions. A p-value of less than
0.05 was considered statistically signiﬁcant. All analyses were
performed using IBM SPSS statistical software version 20.0.3. Results
All the 40 patients enrolled in this study successfully under-
went both DCE-MRI and DWI for their suspicious breast
ﬁndings and had a histopathology reference standard test for
their index lesion.
Histopathology analyses revealed malignant tumors in 18
patients (45%), 16 of which were invasive ductal carcinomas
(IDCs) (Fig. 1) and two were invasive lobular carcinomas
(ILCs) (Fig. 2).ell deﬁned oval and globular lesions ranging in size between a few
signal intensity. B – DCE-MRI shows moderate homogenous
WI’s lesions show facilitated diffusion. D – Corresponding ADC
Fig. 4 A – Axial T2WI shows a 7.6 · 7.6 · 6.3 cm well deﬁned lobulated heterogenous large mass occupying most of the left breast with
compression of adjacent breast parenchyma and displays multiple small hyperintense locules separated by hypo intense septa. B – DCE-
MRI: The lesion shows heterogeneous enhancement. C – DWI-MR revealed restricted diffusion. D – Corresponding ADC map. The mean
ADC= 0.83 · 103 mm2/s.
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Six patients had ﬁbroadenomas, one of them had multiple
bilateral lesions and biopsy was taken from the largest one
(Fig. 3), two papillomas, four fat necrosis, six abscesses
(Fig. 4) and two phylloid tumors.
In all the 40 patients, wemeasured theADCvalue of the index
lesion. The median ADC of malignant lesions was
0.81 · 103 mm2/s and that of benign lesions was 1.2 ·
103 mm2/s.
ADC values were signiﬁcantly lower in malignant lesions
compared to benign lesions (p< 0.001). ROC curves of the
ADC values are represented in (Fig. 5). The best cutoff level
for ADC derived from the ROC analysis was
1.25 · 103 mm2/s, giving 100% sensitivity and 77.3%
speciﬁcity.
4. Discussion
DWI provides important biological information about the
composition of tissues and their physical properties (11). The
information is obtained noninvasively and without the need
for contrast administration (12). DWI reﬂects some tissue
characteristics, such as perfusion and diffusion. Diffusion is
mainly affected by cellularity, presence of edema, ﬁbrosis,
and necrosis of the tissue (9). The perfusion effect is seen when
a b value less than 400 s/mm2 is used (10). Hence this study wasdone with b values = 400 and 800 s to eliminate perfusion
related diffusion.
DWI is quantiﬁed by ADC values, which calculates the
amount of water diffusion through the tissues. ADC values
vary between malignant and benign breast masses, whereby
the ADC values of malignant breast lesions are usually lower
than those of benign lesions, indicating restricted water diffu-
sion and increased cellularity. The ADC values of benign
lesions are higher, reﬂecting normal cellularity with no restric-
tion of water movement. However, there is overlap between
both entities as benign breast changes can give low ADC val-
ues and mimic malignancies (13–15).
Abscess has low ADC values similar to malignant tumors.
The area of low ADC value within an abscess usually gives
high signal intensity on T2-weighted images, which indicates
the high water content and high viscosity of the abscess. In
clinical practice, physical examination ﬁndings should be con-
sidered when assessing these entities, thereby simplifying the
radiologic diagnosis (16).
In our study there were 6 cases of abscess, all showed
restricted diffusion with the mean ADC value
0.85 · 103 mm2/s. This diffusion restriction can lead to false
positive results by DWI.
Both benign and malignant papillary lesions show high cel-
lularity and vascularization, and commonly presented with
restricted diffusion which may create problems in the
Fig. 5 ROC curve demonstrating area under the curve for ADC
in detecting breast malignancy.
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and DWI (13).
In our study, there were two cases of benign intraductal
papilloma that showed diffusion restriction with mean ADC
value of 0.91 · 103 mm2/s.
Small breast lesions measuring less than 5 mm and necrotic
lesions are difﬁcult to delineate on DWI and as such can give
inaccurate ADC value calculations. Liberman et al. (17) stated
that there is a low likelihood for lesions <5 mm to be cancer-
ous. In the present study, the selected lesions were set above
1 cm in size. The smallest lesion was a 1.2 cm ﬁbroadenoma.
The role of DWI, with the calculation of the ADC values
on the 1.5T MR scanner, in differentiation between benign
and malignant breast lesions has been evaluated in the previ-
ous studies (7,17,18). The current study obtained statistically
signiﬁcant differences between benign and malignant lesions
(p< 0.001) and our results are comparable to other studies
performed at 1.5T scanners (7,13,17–20).
The cut-off ADC value for benign and malignant lesions
was determined in our study as 1.25 · 103 mm2/s, giving
100% sensitivity and 77.3% speciﬁcity with an overall accu-
racy of 92.45%. Using different ADC cut values, different
studies showed variation in DWI sensitivity and speciﬁcity.
Tozaki and Maruyamain (21) used a cutoff ADC value of
1.13 · 103 mm2/s and achieved a speciﬁcity of 67% and a sen-
sitivity of 97%. Orguc et al. (22) used a cut-off value of
1.46 · 103 mm2/s for ADC in receiver operating characteristic
analysis and 95% sensitivity and 85% speciﬁcity were achieved
for differentiating between benign and malignant lesions.
Spick et al. (23) demonstrated that an ADC cut-off level of
1.258 · 103 mm2/s would produce a sensitivity and speciﬁcity
for the ADC measurements of 80% and 79.8% respectively.
Yoshikawa et al. (24) demonstrated a correlation between
ADC and histological type. The present study did not establish
a signiﬁcant correlation when comparing tumor grades, tumorsize to ADC values. The poor correlation of ADC values with
the prognostic factors of the malignant tumors in this study
may be due to the small sample size.
In conclusion, the present study supports the usefulness of
quantitative DWI assessment in the characterization of breast
lesions using 1.5T MRI. The results from the present study and
previous studies provide consistent evidence that DWI is a
good diagnostic tool for breast lesion characterization and
when added to the standard breast MRI protocols, it aids
the diagnosis of breast cancer.
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